Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Breast Cancer Metastatic × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 131 Breast Neoplasms 103 Prostatic Neoplasms 50 Lung Neoplasms 47 Carcinoma, Non-Small-Cell Lung 44 Colorectal Neoplasms 37 Urinary Bladder Neoplasms 26 Ovarian Neoplasms 26 Carcinoma, Hepatocellular 26 Pancreatic Neoplasms 25 Multiple Myeloma 25 Stomach Neoplasms 23 Hematologic Neoplasms 20 Leukemia, Myeloid, Acute 19 Disease 19 Brain Neoplasms 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Esophageal Neoplasms 18 Colonic Neoplasms 18 Thyroid Neoplasms 17 Melanoma 17 Lymphoma 16 Leukemia 16 Liver Neoplasms 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Carcinoma, Renal Cell 15 Neoplasm Metastasis 14 Kidney Neoplasms 14 Head and Neck Neoplasms 14 Rectal Neoplasms 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06706570 2026-03-24

PIK3CA Mutational Status Assessment

European Institute of Oncology

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡